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Abstract
Background: Multiparameter flow cytometry has revealed extensive phenotypic and functional heterogeneity of CD4 T cell
responses in mice and humans, emphasizing the importance of assessing multiple aspects of the immune response in
correlation with infection or vaccination outcome. The aim of this study was to establish and validate reliable and feasible
flow cytometry assays, which will allow us to characterize CD4 T cell population in humans in field studies more fully.
Methodology/Principal Findings: We developed polychromatic flow cytometry antibody panels for immunophenotyping
the major CD4 T cell subsets as well as broadly characterizing the functional profiles of the CD4 T cells in peripheral blood.
We then validated these assays by conducting a pilot study comparing CD4 T cell responses in distinct populations of
healthy adults living in either rural or urban Kenya. This study revealed that the expression profile of CD4 T cell activation
and memory markers differed significantly between African and European donors but was similar amongst African
individuals from either rural or urban areas. Adults from rural Kenya had, however, higher frequencies and greater
polyfunctionality among cytokine producing CD4 T cells compared to both urban populations, particularly for ‘‘Th1’’ type of
response. Finally, endemic exposure to malaria in rural Kenya may have influenced the expansion of few discrete CD4 T cell
populations with specific functional signatures.
Conclusion/Significance: These findings suggest that environmentally driven T cell activation does not drive the
dysfunction of CD4 T cells but is rather associated with greater magnitude and quality of CD4 T cell response, indicating that
the level or type of microbial exposure and antigenic experience may influence and shape the functionality of CD4 T cell
compartment. Our data confirm that it is possible and mandatory to assess multiple functional attributes of CD4 T cell
response in the context of infection.
Citation: Roetynck S, Olotu A, Simam J, Marsh K, Stockinger B, et al. (2013) Phenotypic and Functional Profiling of CD4 T Cell Compartment in Distinct
Populations of Healthy Adults with Different Antigenic Exposure. PLoS ONE 8(1): e55195. doi:10.1371/journal.pone.0055195
Editor: Ann M. Moormann, University of Massachusetts Medical School, United States of America
Received September 7, 2012; Accepted December 19, 2012; Published January 28, 2013
Copyright:  2013 Roetynck et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the MRC National Institute for Medical Research (U117584248), London, UK, and a Wellcome Trust Senior Fellowship Award
to BCU (079082). This is part of the EviMalar European Network of Excellence supported by the Framework 7 programme of the European Union. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jlangho@nimr.mrc.ac.uk
Introduction
CD4 T cells are a central component of the immune response to
a wide variety of pathogens. Nevertheless, in most infections, the
precise mechanisms of CD4 T cell mediated protection remain
uncertain. Besides their mandatory role in inducing humoral
immunity, CD4 T cells also produce cytokines, which control
infection and regulate responses to limit pathology, and they seem
to be required for the optimization and maintenance of CD8 T
cell memory [1]. On the other hand, there are examples where
they can drive pathogenesis [2,3] and, despite extensive efforts, in
most instances, such as in malaria, it is still unclear under which
circumstances CD4 T cells mediate either protective immunity or
immunopathology.
The CD4 T cell memory pool comprises a heterogeneous
population of antigen (Ag)-experienced cells extremely diverse, not
only in terms of Ag specificity, but also surface phenotype, effector
function and memory potential (reviewed in [4,5,6]). These
phenotypic and functional properties of CD4 T cell responses
may be modulated by a variety of factors including innate immune
responses, microenvironment, time to Ag exposure as well as Ag
load, availability and persistence [7,8,9]. Until recently, many
studies of CD4 T cell responses focused only on one or a limited
number of T cell attributes, such as magnitude of the response and
expression of one or a few signature cytokines or cell surface
markers, often showing little correlation with disease status or
immunity. This is not surprising given the recent findings showing
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flexibility in CD4 T cell commitment as well as plasticity in their
cytokine secretion profiles (reviewed in [10]) and the existence of
memory cells with overlapping cytokine patterns, which do not
conform to T helper classification [11,12]. In addition, recent
studies of Ag-specific T cell responses to vaccines, or after certain
infections (reviewed in [13,14]), have revealed an enormous
phenotypic heterogeneity and functional diversity within the CD4
T cell population, emphasizing the importance of the quality (i.e.
the combination of different functions at a single cell or cell
population level) of a T cell response, as opposed to its simple
magnitude or response of a single population, in correlation with
clinical outcome. Together, these studies have demonstrated that
the simultaneous assessment of multiple attributes of T cell
function is necessary for the prediction of the outcome of infection
or vaccination.
Multiparameter flow cytometry (FC) [15] allows the simulta-
neous assessment of magnitude, phenotype and multiple functional
characteristics of CD4 T cells, including their differential
expression of surface markers defining distinct populations at
different stages of differentiation [4,16], their cytokine production
as well as their homing receptors profiles [4,17]. The aim of this
study was therefore to establish reliable and feasible assays, which
will allow us to characterize more fully CD4 T cell population in
humans in field studies.
We have designed antibody (Ab) panels for polychromatic FC
analysis of chemokine receptor and activation marker expression
patterns as well as cytokine profiles. In a pilot (‘‘proof-of
principle’’) study, we analysed CD4 T cell responses of healthy
adults, from a rural population of coastal Kenya, and compared
with those of age and sex-matched African and European
individuals, living in urban Kenya. We show that the global
expression profile of CD4 T cell maturation and activation
markers differed significantly between African and European
healthy adults while no major differences were observed amongst
African individuals from either rural or urban areas. Furthermore,
we observed quite distinct patterns of cytokine production between
the rural and the urban populations, with a predominance of
‘‘Th1’’ over ‘‘Th2’’ type of cytokines, a greater number of subsets
expressing multiple cytokines as well as higher frequency of
multifunctional CD4 T cells in the rural community, suggesting
that environmental factors and/or antigenic experience can affect
the functional signature of CD4 T cell response. Although very
little correlation was found between malaria exposure and the
functional attributes of the global response in blood, endemic
exposure to malaria may contribute to the expansion of a few
discrete CD4 T cell populations with specific functional profiles as
a possible mechanism to prevent immunopathology associated
with the infection. Collectively, our data suggest that environ-
mentally driven T cell activation in rural Kenya does not lead to
the dysfunction of CD4 T cell population but is rather associated
with a CD4 T cell cytokine response of higher magnitude and
greater polyfunctionality, suggesting that the level and/or the type
of microbial exposure and antigenic experience may influence and
shape the functionality of CD4 T cell compartment.
Results and Discussion
Characteristics of the Study Population
CD4 T cell responses from 25 healthy adults from rural Kenya
(rural African donors, RA) were analysed and compared to those
from age and sex-matched urban populations of African (urban
African donors, UA, n = 8) as well as European (urban European
donors, UE, n = 8) individuals. The rural population comes from
villages located in the Junju sublocation of Kilifi district [18], while
the urban populations live in the urban area of Kilifi town, in
coastal Kenya. European donors grew up in Europe but were
currently living in Kilifi town at the time of the study.
The Overall Profile of CD4 T cell Differentiation is
Significantly Different between African and European
Individuals but Similar between Rural and Urban
Populations of Healthy African Adults
Upon activation, naı¨ve CD4 T cells develop into effector cells,
which gain progressively functionality with differentiation
[4,13,19]. During this process, they give rise to central memory
(TCM) and effector memory cells (TEM) that will expand rapidly
upon secondary challenge [19,20]. It is possible to define stages of
T cell activation and maturation by differential expression of cell
surface markers, such as CD45RA, CCR7, CD27 and CD28
[4,16,19]. While naı¨ve CD4 T cells express all four markers, they
progressively lose surface expression of these molecules as they
undergo activation and differentiation, such that TCM, or early/
middle effectors, are CCR7+ CD27+ CD28+/2 CD45RA2 and
TEM, or middle/late effectors, are CCR7
2 CD27+ CD28+/2
CD45RA+/2 [4,16,19].
Studies on chronic viral infections in humans suggest that
sustained and chronic antigenic stimulation can result however in
progressive loss of both their ability to produce cytokines and their
memory potential, leading to pro-apoptotic terminally differenti-
ated CD4 T cells, defined as CCR72 CD272 CD282 CD45RA+/
2 [9,14,21]. Since the three different groups of healthy volunteers
(rural and urban African and urban European donors) are likely to
have been exposed to both quantitatively and qualitatively distinct
microbial environments and have had different antigenic experi-
ence, we examined whether this might be reflected on the
distribution of CD4 T cell maturation and activation phenotypes.
We therefore compared the cell surface expression of CD45RA,
CCR7, CD27 and CD28 (panel Table S1) on CD4 T cells in
PBMC. Boolean gating analysis identified 16 subpopulations
expressing each possible combination of markers within the CD4
T cell population (Figure 1, gating strategy is shown in Figure S1).
In all groups, approximately 26% of CD4 T cells could be defined
as naı¨ve as they expressed all 4 markers, in agreement with
previous studies on healthy individuals in the United States [22]
and Burkina Faso [23].
Remarkably, all the 16 possible subpopulations were observed
in all the donors, confirming the great heterogeneity of CD4 T
cells with respect to expression of these markers in PBMC. The
well-described CD4 T cell populations of TCM as well as TEM cells
were present, but also all the intermediate phenotypes, which can
not as yet be ascribed to a specific subpopulation or to a
functionally unique subset [4,16]. Across group comparisons using
Kruskal-Wallis test showed that, out of these 16 subsets, the
frequency of 9 subpopulations was significantly different between
individuals from rural Kenya and the two urban populations of
volunteers. Four phenotypes (CCR7+ CD272 CD28+ CD45RA+;
CCR72 CD27+ CD28+ CD45RA2; CCR72 CD27+ CD282
CD45RA+ and CCR72 CD27+ CD282 CD45RA2, respectively)
were significantly less frequent in the rural population when
compared to the urban African population (P = 0.007; P = 0.01;
P = 0.01 and P = 0.01, respectively). Significant differences were,
for the majority, observed between rural African and urban
European donors. However, they were also, for most of them,
observed between the two urban populations, suggesting that
differences in CD4 T cell subsets between African and European
individuals may be due to either genetic or other environmental
factors rather than their current microbial exposure.
CD4 T Cell Profiling in Rural and Urban Kenya
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The frequency of CD4 T cells exhibiting the CCR72 CD272
CD282 CD45RA+/2 phenotype, defined as terminally differen-
tiated effector memory cells [4,13,16], was very low in all donors
(less than 2%) and there was no significant difference between
rural and urban groups of individuals. Furthermore, differentia-
tion towards a terminal effector stage has been associated with a
decrease in CD28 expression by CD4 T cells and the appearance
of CD282 late effector CD4 T cells [4]. No significant differences
were found in the frequency of CD28 positive and CD28 negative
CD4 T cells between groups (data not shown), further confirming
that the rural population does not have a greater frequency of
CD4 T cells with phenotypic characteristics of terminal differen-
tiation associated with T cell ‘‘exhaustion’’ or dysfunction [24].
In summary, the differentiation and activation marker expres-
sion profiles were found comparable between African individuals
from rural and urban Kenya. This is in complete agreement with a
previous study showing no detectable qualitative differences in the
distribution of lymphocyte subsets in HIV negative healthy adults
living in either a rural or an urban area in Ethiopia [25].
Collectively, our data suggest that environmentally triggered T cell
activation in rural Kenya does not seem to drive the general
exhaustion of CD4 T cells, despite significantly higher levels of
reported chronic and acute conditions in the rural as compared
with the urban setting [26]. Earlier studies, using only CD45RA
and CCR7 or CD27 as markers, found more memory and fewer
naı¨ve T cells in PBMC of African compared to European donors
[23,25,27]. We did not observe similar skewed distribution of CD4
T cell phenotypes, when 4 markers were used to distinguish CD4
T cell types. However, our analysis did reveal more subtle
differences between African and European individuals, mainly in
the Ag-experienced CD4 T cell compartment, suggesting that the
distribution pattern of T cell maturation phenotypes may not be a
strictly direct surrogate parameter of environmentally driven T cell
stimulation, and reflected a more complex relationship between
phenotype and Ag experience.
CD4 T Cell Cytokine Responses from Rural African Donors
are of Higher Magnitude Compared to those of Urban
Individuals
Upon activation, CD4 T cells tailor their response to the type of
invading microbe by differentiating into T helper (Th) cells with
Figure 1. CD4 T cell differentiation and activation profile significantly differs between African and European donors but is similar
between African individuals from either rural or urban Kenya. The differential expression of CCR7, CD27, CD28 and CD45RA by CD4 T cells
was analysed by Boolean gating. Each phenotype (defined by a specific combination of markers) is shown under each subset. Each dot denotes the
expression of each marker indicated on the bottom left. The differentiation stage is specified when a specific phenotype has been ascribed to a
particular stage 4,13,19]. TCM and TEM refer to central memory and effector memory cells, respectively. CD4 T cell subsets were then ordered
according to the number of markers they express specified by the horizontal bars of different colours showing these combinations of 4, 3, 2, 1 or 0
marker. The frequency of each subset is represented as a percentage of the total CD4 T cells (medians and 95% confidence intervals are shown for
each group) and was compared between the three groups (rural African (RA, n = 25), urban African (UA, n = 8), and urban European donors (UE,
n = 8)). Differences in CD4 T cell phenotypic profile among groups were tested using Kruskal-Wallis test and where significance was obtained,
nonparametric Mann-Whitney U test was used for pair-wise analysis of the differences between groups. Statistically significant P-values (,0.05) are
indicated by an asterisk (in red for Kruskal-Wallis or black for Mann-Whitney tests, respectively). *indicates P,0.05, **P#0.01 and ***P#0.001.
doi:10.1371/journal.pone.0055195.g001
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specific effector functions, characterized by distinct profiles of gene
expression and cytokine production.
To determine whether CD4 T cell pool of healthy adults living
in rural and urban environments have different functional profiles,
we analysed the production of cytokines characteristic of different
CD4 T cell subsets, in PBMC from each group of individuals.
CD4 T cells from the rural African individuals were the most
responsive to ex vivo stimulation with mitogen as both the
percentage of CD4 T cells which had upregulated CD69 and
the mean level of CD69 expression per cell (data not shown) were
significantly higher when compared to those from the urban
African and European donors (Figure 2A, P = 0.03 and
P = 0.0003, respectively). The total frequency of CD4 T cells
expressing any cytokine was significantly higher in the rural
African donors compared with those from both urban African and
European individuals (Figure 2B, P = 0.03 and P = 0.007 respec-
tively) (gating strategy shown in Figure S2), with an overall lower
responsiveness and decreased frequency of cytokine secreting CD4
T cells in European compared to African donors. These
differences in cytokine secreting CD4 T cell population between
rural and urban African communities and also between African
and European donors could reflect differences in the level of
microbial exposure or in Ag experience across the groups.
We next determined the frequency of each individual cytokine
response by CD4 T cells from each study population (Figure 3A).
Comparisons across the three groups using Kruskal-Wallis test
revealed that, except for IL-4, the total frequency of CD4 T cells
producing each cytokine differed between groups. One of the most
striking differences between rural and urban populations was
observed for TNFa expression. Individuals from rural Kenya had
approximately 3 times more CD4 T cells producing TNFa
compared to both urban groups (P = 0.0003 and ,0.0001 when
compared to UA and UE, respectively). This observation is of
particular interest given the dual role of this inflammatory cytokine
in both protection and immunopathology associated with infec-
tions [28,29,30].
The frequency of IL-10 producing CD4 T cells was low but
significantly higher in the rural population compared to either
urban group (P = 0.0007 and P = 0.0006, when compared to UA
and UE, respectively). Further pair-wise comparisons showed that
CD4 T cells producing all of the other cytokines, with the
exception of IL-4, were significantly more frequent in the rural
group compared to the European volunteers. Similarly, the
frequency of CD4 T cells producing IL-21, IL-22 or IL-9 was
also significantly elevated in rural African individuals when
compared to urban African donors (P = 0.03, P = 0.009,
P = 0.0004, respectively). There was a similar trend of higher
frequencies of IFNc, IL-2 or IL-17 producing CD4 T cells
between the two groups of African donors; however, these
differences did not reach significance.
Despite the differences in the magnitude of the individual
cytokine responses across the groups, IL-2 and IFNc, together with
TNFa and IL-4 producing CD4 T cells represented the majority
of the cytokine secreting cells in all three study groups (Figure 3B).
The relative proportion of cells producing TNFa and/or IL-22
was significantly higher in CD4 T cells from rural individuals
compared with that of both groups of urban volunteers (P = 0.0003
and 0.04 for TNFa, and P = 0.02 and 0.02 for IL-22, when
compared to UA and UE, respectively). By contrast, the rural
population had a significantly smaller fraction of IL-4 expressing
CD4 T cells compared to the urban individuals (P = 0.01 and
0.04 when compared to UA and UE, respectively). Interestingly,
the composition of CD4 T cell cytokine response was extremely
similar between the two urban groups.
Collectively, these data show that, in general, African individ-
uals from a rural community have a greater overall cytokine
response compared to individuals from an urban area, suggesting
that the magnitude of the CD4 T cell cytokine response might
represent a proxy marker for environmentally driven T cell
activation. In addition, despite a reported high prevalence of
helminthic infection in the area [31], their CD4 T cell functional
profile was dominated by ‘‘Th1’’ signature cytokines, suggesting
that their rural environment might contain numerous pathogens
triggering this type of response. These observations are in
contradiction with the idea that the host immune system in
developing countries is biased towards a ‘‘Th2’’ type of profile and
Figure 2. The magnitude of CD4 T cell cytokine response is higher in the rural population. CD4 T cell cytokine responses from adults
living in rural Kenya (RA, n = 25) were analysed and compared to those from urban populations of African (UA, n = 8) and European (UE, n = 8) donors.
The functional signatures of CD4 T cells were determined after non-specific in vitro stimulation with PdBU and ionomycin via the analysis of an array
of functions including IFNc, IL-2, IL-10, IL-17, TNFa, IL-21, IL-22, IL-4 and IL-9 secretion (panels 1-3 Table S1). (A) The total frequency of CD69 positive
CD4 T cells following stimulation was expressed as a percentage of total CD4 T cells. (B) The total frequency of CD4 T cells expressing at least one
cytokine was expressed as a percentage of CD4 T cells (%). Horizontal bars indicate the mean (95% confidence intervals are represented) for each
group. Nonparametric Mann-Whitney U test was used to analyse differences in the T cell responses between groups. Statistically significant P-values
(, 0.05) are indicated by an asterisk (P,0.05 *; P#0.01 **; P#0.001 ***).
doi:10.1371/journal.pone.0055195.g002
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that the chronic immune activation, that might occur in rural
Africa, may be associated with decreased cellular responses to
mitogen stimulation [27,32,33]. All together, this indicates that
studies based on the comparison between African cases and
European controls must be interpreted with caution, as European
donors may not be appropriate controls when CD4 T cell
responses are assessed by their single magnitude; however, they
seem to represent acceptable controls when the comparison is
based on the composition of the T cell cytokine response.
Rural African Donors have a Highly Polyfunctional CD4 T
Cell Pool Compared to the Urban Populations
The simultaneous measurement of a variety of cytokines enables
the distinction between numerous T cell subpopulations with
specific functional signatures. The delineation of T cells into
Figure 3. Functional analysis of CD4 T cell cytokine response in the three groups of donors. (A) The frequency of CD4 T cells positive for
each cytokine (IFNc, IL-2, IL-10, IL-17, TNFa, IL-21, IL-22, IL-4 and IL-9, respectively) is represented as a percentage of CD4 T cells (mean (%) and 95%
confidence intervals are indicated) and compared between the 3 groups of donors (rural African donors, RA, n = 25; urban African donors, UA, n = 8;
urban European donors, UE, n = 8). Nonparametric Mann-Whitney U test was used to analyse differences in the T cell responses between groups. An
Asterisk indicates statistically significant P-values (, 0.05) (*P,0.05; **P#0.01; ***P#0.001). The pie charts in B show the relative frequency of the
different cytokine responses within the overall cytokine producing CD4 T cell population. The mean frequency of CD4 T cells positive for each
cytokine is represented as a fraction of the total cytokine response by CD4 T cells (%) and compared between the 3 groups of donors (RA, n = 25; UA,
n = 8; UE, n = 8).
doi:10.1371/journal.pone.0055195.g003
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distinct functional populations defines the quality of the response
[13]. Recently, a series of studies have shown that the quality of a
T cell response is an important parameter in defining clinical
immune correlates [13,14].
To detect the different cytokines in CD4 T cells from the three
groups of donors, we used three Ab panels (panels 1–3, Table S1),
measuring up to 5 cytokines simultaneously. We first analysed the
patterns of cytokine positive CD4 T cells from the three groups for
each Ab panel and ordered the different subsets according to the
number of cytokines they simultaneously express. Using all three
panels of anti-cytokine Ab, the majority of cytokine secreting CD4
T cells were expressing one or two cytokines, although subsets
producing 3 or even 4 cytokines were observed (Figure S3).
When IFNc, IL-2, IL-17, IL-10 and TNFa production was
simultaneously assessed using panel 1 (Table S1), 17 out of the 32
possible distinct subsets of CD4 T cells were observed in all the
donors (Figure 4A). With this panel of cytokines, CD4 T cells from
rural African individuals had a qualitatively different functional
profile compared with the urban donors. There was more diversity
among their cytokine producing CD4 T cells compared to the two
urban groups, as some subsets (represented by orange bars),
particularly those positive for more than 2 cytokines, were only
observed within the CD4 T cells of this group. In addition, there
were a significantly greater frequency of CD4 T cells from rural
African donors producing 2, 3 or 4 cytokines and a decreased
frequency of CD4 T cells expressing single cytokine compared to
the urban donors. Among these multifunctional subsets, rural
African donors had a significantly higher frequency of IFNc/IL-2/
TNFa triple producers compared to the two urban groups
(P = 0.02 and P = 0.0005 when compared to UA and UE,
respectively). This observation is interesting as several studies
have found a correlation between this particular CD4 T cell subset
and both protection following immunization and successful
outcome of several infections, driving a ‘‘Th1’’ type of response
([34], reviewed in [13,14]).
When IFNc, IL-2, IL-17, IL-21 and IL-22 production by CD4
T cells was simultaneously analysed (panel 2, Table S1), single
cytokine secreting CD4 T cells were again the most highly
represented populations within CD4 T cells from all three groups,
although different double producers and a few populations
producing 3 cytokines were also present (Figure 4B). There was
a similar bias towards an increase in the relative frequency of
subsets co-expressing two or 3 cytokines and a decreased
proportion of single cytokine-producing CD4 T cell subsets in
rural individuals when compared with both urban groups (Figure
S3B).
Finally, when ‘‘Th2/Th9’’ type of functional profiles were
analysed and the production of IL-2, IL-10, IL-4 and IL-9 was
simultaneously evaluated (panel 3, Table S1), there was remark-
ably little diversity in the functional profile of CD4 T cells subsets.
The overall response was almost exclusively limited to subsets
expressing a single cytokine (Figure S3C). One possible explana-
tion is that other cytokines, such as IL-5 and IL-13, may be
important to consider for the analysis of the functional profile of
‘‘Th2’’ type of responses. Unfortunately, it was not possible to
include these mediators in our analysis, due to the lack of reagents
available. Nonetheless, IL-9 and IL-4 production profiles differed
significantly between the rural and urban populations of African
individuals (Figure S3C). Few CD4 T cell populations expressing
IL-4 and/or IL-9 in combination with other cytokines were
observed and found in general more frequent in the rural African
individuals when compared to the urban group of African
individuals. Since ‘‘Th2’’ type of responses, and particularly IL-
9, have been proposed to play a role in immunity against
helminthic infections [35], these responses might reflect differences
in exposure to this type of pathogen between the two African
populations. A high prevalence of soil-transmitted helminthic
infections has been reported in Coastal Kenya [36], where rural
residence has been associated with higher risk of infection
compared to urban setting [37]. In addition, Bejon et al have
reported a prevalence of 25% of gastrointestinal helminth infection
and 50% of eosinophilia in young children in the Junju area [31].
Further studies, measuring for instance IgE or eosinophilia levels
in these individuals are therefore required to explore the possible
association of these responses with exposure to helminthic
infection in this area.
No major differences were observed in the functional profile of
CD4 T cell responses between the two urban groups, further
indicating that European donors may be acceptable controls for
studies of CD4 T cell cytokine responses from African donors
based on the quality of the response.
We next expressed each individual response (i.e. each specific
combination of cytokines) as a fraction of the total CD4 T cell
cytokine response (Figure S3) and grouped the different functional
subsets according to the number of cytokines they simultaneously
express to determine the overall quality of CD4 T cell responses in
each study population (Figure 5). Confirming the data in Figure 4,
for all Ab panels, the majority of CD4 T cells from all the
individuals were single cytokine secreting cells. However, we
observed a higher fraction of multifunctional CD4 T cells (i.e.
CD4 T cells expressing more than one cytokine) with panel 1
(Figure 5A) compared to the other Ab panels (Figure 5B and 5C).
In addition, with this panel, significantly fewer CD4 T cells from
PBMC of the rural population expressed only one cytokine, while
multifunctional CD4 T cells represented a higher percentage (35%
(mean)) of their total CD4 T cell cytokine response compared to
the urban groups (Figure 5A). Similar trends were observed for
panels 2 and 3, however they did not reach significance (Figure 5B
and 5C).
This analysis indicates that CD4 T cell responses of rural
African individuals are characterized by the presence of many
distinct functional cell populations, particularly ‘‘Th1’’ type of
responses, compared with those of individuals living in an urban
area. Our data suggest that the extent of polyfunctionality of the
response as well as the frequency of CD4 T cells co-expressing
multiple cytokines may reflect the level of environmentally driven
T cell stimulation.
Influence of Endemic Exposure to Malaria Infection on
the Phenotypic and Functional Attributes of CD4 T Cell
Responses
One of the known differences in the pathogenic environment of
the three groups of donors was the level of exposure to malaria.
The rural population lives in a sublocation of Kilifi district, where
malaria infection is endemic [18], while the urban donors live in
Kilifi town, where there is no malaria. In line with this, none of the
urban donors had detectable IgG Ab specific for P. falciparum
(Apical Membrane Antigen (AMA)-1, Merozoite Surface Protein
(MSP)-142, Merozoite Surface Protein (MSP)-2 and total P.
falciparum schizont extract (PfSE)), whereas these Ab were
detectable in the plasma of all rural African donors at variable
levels (Figure S4), suggesting that these individuals have been
exposed to malaria [38] and have developed clinical immunity to
the infection [39,40,41]. In addition, malaria exposure indexes
[42] were estimated for a period of time starting in 2009 until 2010
and confirmed that all donors were likely to have been exposed to
the infection during the last 2 years preceding this cross-sectional
survey (data not shown). However, none of the exposed volunteers
CD4 T Cell Profiling in Rural and Urban Kenya
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was infected with P. falciparum at the time of sampling as confirmed
by both negative blood smears and semi-quantitative PCR that
detects all four human malaria species [43] (data not shown).
As described above, we could not detect any skewed distribution
of the major subtypes of CD4 T cells between rural African
(malaria exposed) and urban African individuals (not exposed),
suggesting that endemic exposure to malaria does not affect the
global CD4 T cell maturation profile in peripheral blood. This
observation is consistent with a very recent study showing that
terminally differentiated CD4 T cells, defined as CD45RA+
CD62L2, represented less than 1% of the total CD4 T cell pool of
both healthy children and adults living in a malaria holoendemic
region in western Kenya [44].
Although we found no evidence of ‘‘exhausted’’ CD4 T cells
based on our panel of cell surface markers, more detailed and
larger studies of P. falciparum-specific CD4 T cells in immune adults
and children presenting with different severity of manifestations of
malaria infection are required to analyse how endemic exposure
and/or infection by P. falciparum may impact on the phenotypic
characteristics of CD4 T cell compartment, including PD-1 and
other markers [24,45].
To explore the relationship between the ability of CD4 T cells
to produce specific cytokines and malaria exposure, correlation
between the frequency of each cytokine response and antimalarial
Ab levels or malaria exposure indexes was assessed by calculating
the Spearman’s correlation coefficient. Interestingly, among the
exposed donors, only the frequency of IFNc producing CD4 T
cells varied significantly with both antimalarial Ab levels (Spear-
man r = 0.56, P = 0.005) (Figure 6A) and malaria exposure indexes
(Spearman r = 0.44, P = 0.03) (Figure 6B). This is in complete
agreement with longstanding evidence for a strong bias towards a
‘‘Th1’’ response associated with malaria infection and the idea that
this cytokine may be a biomarker of recent exposure and/or
clinical immunity to malaria [46], although it is likely to be the
case for many infections triggering this type of response. Likewise,
a positive correlation was found between the frequency of IL-10
producing CD4 T cells and malaria exposure indexes (Spearman
r = 0.48, P = 0.02) (Figure 6B); however, no correlation was found
with P. falciparum-specific Ab levels (data not shown). Although we
will need to characterize the functions of P. falciparum-specific CD4
T cell responses, this is consistent with a previous study reporting
high frequencies of IL-10 expressing CD4 T cells in children with
uncomplicated malaria [47]. Nevertheless it is similarly possibly
the case after exposure to many infections, explaining in part why
the correlation observed was weakly significant. No correlation
was found between malaria exposure and CD4 T cell expression of
any other cytokines (data not shown).
IL-10 producing CD4 T cells were found more frequent in rural
donors and a certain proportion also co-expressed IFNc, whereas
IFNc/IL-10 double producers were poorly represented in the
CD4 T cell response from urban African donors and none was
detectable within the CD4 T cells from European donors
(Figure 4A and S5A). In addition, rural African individuals had
a significantly decreased proportion of IFNc single producers,
compared to the urban volunteers (P = 0.009; P = 0.0005 when
compared to UA and UE, respectively) (Figure S3A and S5A).
When we then analysed the possible effect of malaria endemic
exposure on the quality of IFNc and IL-10 response, there was a
trend towards a positive correlation between the relative frequency
of CD4 T cell subset co-expressing IFNc and IL-10 and malaria
exposure indexes (Spearman r = 0.48, P = 0.017, Figure S5B),
while we found no significant correlation with antimalarial Ab
levels (data not shown). This finding was particularly notable as
this CD4 T cell subset has previously been observed in populations
living in malaria endemic areas after polyclonal stimulation with
mitogen [47] or malaria-Ag specific activation of T cells [48], and
we have shown that IL-10 production by IFNc secreting CD4 T
cells is a critical component of protection against severe malaria
immunopathology in the mouse model of P. chabaudi infection
[49]. All together, these results suggest that malaria endemic
exposure, among other infections [50], may drive the expansion of
this specific population of IFNc+/IL-10+ CD4 T cells and this
should be addressed in a larger study. By contrast, the relative
frequency of IFNc single expressing CD4 T cells was inversely
correlated with the level of malaria exposure, estimated by
exposure indexes (Spearman r =20.47, P = 0.02, Figure S5B) but
not with antimalarial Ab levels (data not shown). Of note, no direct
correlation was found between Ab levels of any specificity and
exposure indexes (data not shown). Acquisition and maintenance
of antimalarial Ab depend on exposure to malaria infection;
however, in adults who have acquired a significant degree of
immunity to the infection, they are usually maintained even if
parasite prevalence has fallen [51], which might partially explain
the discrepancies observed.
Finally, no significant correlation was found between any other
subset expressing IFNc (shown in Figure 4) and malaria exposure
(data not shown). Similarly, the relative frequency of multifunc-
tional T cells (Figure 5) did not vary significantly with malaria
exposure (i.e. no significant correlation was found with either
antimalarial Ab levels or exposure indexes) (data not shown).
All together, we found only very little effect of malaria endemic
exposure on the global phenotypic and functional attributes of
CD4 T cell population in peripheral blood. Even though larger
studies might be needed to show a significant effect, this is not
surprising as these individuals are probably exposed to a myriad of
microbial antigens hence increasing the memory pool to these
pathogens while endemic malaria exposure drives or limits the
expansion of only few discrete subpopulations of CD4 T cells. This
is in complete agreement with growing body of evidence
suggesting that multiple combinations of functions can be
identified following polyclonal stimulation of CD4 T cells but
Ag-specific CD4 T cell responses seem to be generally restricted to
some particular subsets [52,53].
Conclusion
We have developed reliable and feasible assays, which allow us
to draw the phenotypic profile as well as a very detailed picture of
CD4 T cell cytokine responses, reflecting the global functional
Figure 4. The functionality of CD4 T cell pool differs between rural and urban populations. CD4 T cell cytokine responses from rural
African donors (RA, n = 25) were analysed by assessing simultaneously IFNc, IL-2, IL-10, IL-17 and TNFa expression using panel 1 (A) or the expression
of IFNc, IL-2, IL-17, IL-21 and IL-22 using panel 2 (B) (Table S1). These responses were then compared to those from urban African (UA, n= 8) and
European donors (UE, n = 8). The frequency of each CD4 T cell subset expressing the particular combination of cytokines, shown in the panel below
each plot, is represented as a percentage of total CD4 T cells (mean (%) and 95% confidence intervals are indicated) for each group of donors. Each
dot designates positivity for the cytokine indicated on the bottom left. Amongst the array of theoretically possible cytokine combinations, those
observed are represented with black dots while those designated with grey dots were not observed. Orange bars represent the subpopulations that
were observed among the CD4 T cells of the rural African donors but were completely absent in the CD4 T cells of both urban groups. Horizontal bars
of different colors show these combinations of 5, 4, 3, 2 or 1 cytokine.
doi:10.1371/journal.pone.0055195.g004
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Figure 5. Rural individuals have a higher frequency of multifunctional CD4 T cells compared to urban donors. The different functional
subsets of CD4 T cells (represented in Figure S3) were grouped by colour according to the number of cytokines they simultaneously express (the
subsets expressing 5 cytokines are in purple, 4 in red, 3 in green, 2 in blue or 1 in yellow). For the functional profiles to be compared between the
groups irrespective of any differences in frequency, the responses were normalized. The total number of CD4 T cells positive for at least one cytokine
was considered as 100%. The frequency within the CD4 T cell population of the single, double, triple, quadruple and quintuple producers was
calculated as a fraction of the total cytokine response by CD4 T cells and expressed as a percentage and is shown for each group of donors (rural
African (RA, n = 25), urban African (UA, n= 8) and urban European donors (UE, n = 8)) (medians (%) and 95% confidence intervals are indicated for
each group). A shows the results for panel 1; B and C represent the data obtained with panel 2 and 3 (Table S1), respectively. The cytokines measured
simultaneously using the different Ab panels are indicated above each plot. Differences in CD4 T cell responses across groups were tested using
Kruskal-Wallis test (data not shown) and where significance was obtained, Mann-Whitney U test was used for pair-wise analysis of the differences
between groups. Statistically significant P-values (, 0.05) are indicated in (A) by an asterisk (P,0.05 *; P#0.01 **; P#0.001 ***).
doi:10.1371/journal.pone.0055195.g005
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potential of CD4 T cell compartment in humans. Despite the
small sample size in this pilot study, these assays revealed that
there were no major differences in the distribution of CD4 T cell
activation and memory phenotypes but that ‘‘Th1’’ type of
cytokine profiles differed the most between rural and urban
African individuals. With the caution that our assays might not be
sensitive enough to fully characterize ‘‘Th2’’ type of response,
there was a predominance of ‘‘Th1’’ over ‘‘Th2’’ type of cytokines
in the global CD4 T cell cytokine expression profile of the rural
community. The best quality, i.e. the highest number of subsets
exhibiting distinct cytokine combinations, was found for this type
of response. This observation was particularly interesting given
long-lasting evidence for a strong bias towards a ‘‘Th1’’ response
induced by many pathogens. In addition, rural African donors had
22% (mean of the overall analysis using the 3 Ab panels) of their
cytokine secreting CD4 T cell population represented by
multifunctional T cells, as opposed to 15% and 10% found for
the urban African and European individuals, respectively. Our
observations indicate that environmentally triggered T cell
stimulation in rural Kenya leads to higher magnitude of cytokine
response as well as an increase in multifunctional cells within the
total CD4 T cell pool, while the presence of a dominant single
cytokine producing CD4 T cell population seems associated with
differential Ag experience in urban Kenya. CD4 T cell responses
from the rural community were similar to those typically observed
in the models of viral infections with Ag persistence but low levels
of Ag exposure [9], whereas the predominance of single cytokine
producing cells was associated with the presence of persistent and
high levels of viral Ag [9]. Our observations do not support the
general idea that high prevalence of chronic infectious diseases in
developing countries causes persistent immune activation leading
to hyporesponsiveness and anergy of T cell compartment [32,33].
However, our results fit well the observations done with the model
of Leishmania major infection, in which the persistence of low level
infection or repeated exposure to Ag seem required to maintain a
high frequency of multifunctional CD4 T cells [34,54,55].
Collectively, these data support the idea that the functionality of
CD4 T cell response seems to be influenced by the conditions of
Figure 6. Total frequency of IFNc and/or IL-10 expressing CD4 T cells correlates with malaria exposure. The percentage of total CD4 T
cells positive for either IFNc or IL-10 is plotted against either antimalarial Ab response, expressed by the number of Ag for which the Ab reactivity was
defined as ‘‘high’’ levels (score between 0 and 4) (A), or malaria exposure indexes (B). Spearman’s correlation coefficients r and P-values are indicated
for each plot.
doi:10.1371/journal.pone.0055195.g006
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Ag exposure and persistence and that the quality of CD4 T cell
response may represent a proxy marker of environmentally driven
T cell activation and Ag stimulation.
The associations between exposure to malaria and the relative
frequency of some IFNc-secreting CD4 T cell subsets suggest that
malaria exposure could drive or limit the expansion of some
discrete CD4 T cell subpopulations with specific functional profiles
as a possible mechanism to control the infection or prevent
immunopathology. The next step would be to analyse cytokine
profiles of Plasmodium-specific CD4 T cells in malaria endemic
populations in the context of larger longitudinal studies in order to
link these functional signatures to protection or immunopathology
associated with the infection.
Materials and Methods
Study Participants
This study took place in the Kenyan coastal region at KEMRI/
Wellcome Trust Research Programme (WTRP) centre in Kilifi.
Donors were enrolled after providing individual written informed
consent. The rural population lives in the Junju sublocation of
Kilifi district, a remote rural area, sparsely populated with limited
infrastructure and poor housing. Inhabitants are predominantly
farmers, commonly maintaining domestic animals and living
mainly in stick and mud-built houses surrounded by agricultural
lands [18]. 25 adults from this area were enrolled in the study. The
mean age of the donors was 30 years (range: 20–50) and 72% were
female. 16 age- and sex-matched African (n = 8) and European
(n = 8) individuals, living in the urban area of Kilifi town, were
used for comparison. Kilifi town is a coastal urban centre lying
along the shores of the Indian Ocean. The urban African
volunteers were all middle class Kenyans working at KEMRI/
WTRP. European individuals were living in Kilifi at the time of
the study but grew up and spent most of their life in urban areas in
Europe before moving to Kenya. Several socio-economical studies
comparing a rural and an urban area in Kilifi district in Coastal
Kenya have shown disparities in terms of economical and social
environments and personal development between the two areas
and identified significantly higher levels of reported chronic and
acute conditions in the rural as compared with the urban setting
and differences in treatment-seeking patterns between settings
[26,56].
Junju is a stable malaria endemic area with two annual
transmission seasons (from May to August and from October to
December) and a parasite prevalence of 30% [18]. Samples were
collected in a post-transmission season cross-sectional survey from
December 2010 to February 2011. Absence of detectable
parasitaemia at the time of sampling was checked for every donor
with slide microscopy and confirmed by semi-quantitative PCR
that detects all four human malaria species [43]. None of the
urban volunteers has been exposed to malaria.
Ethics Statement
The study was approved by the Kenyan Medical Research
Institute, Ethical Review Committee under the SSC protocol
number 1131, the Oxford Tropical Ethics Committee, protocol
030-06 as well as the National Research Ethics Service Committee
at the MRC National Institute for Medical Research, reference
08/H0723/94.
Parasite and P. falciparum Schizont Extract Preparation
P. falciparum parasites from the 2B2 strain were cultured in vitro
using the method adapted from Trager et al [57]. The 2B2 strain is
a clone derived from the laboratory strain ITO4 [58,59]. Parasites
were tested weekly for the absence of mycoplasma contamination
by PCR following procedure described in [60]. Schizont-infected
erythrocytes were isolated from sorbitol-synchronized cultures
with magnet-activated cell sorter (MACS, Miltenyi). PfSE was
prepared by two rapid freeze-thaw cycles in liquid nitrogen and a
37uC water bath. Extracts of uninfected erythrocytes were
prepared similarly.
Recombinant Antigens
P. falciparum-specific IgG responses were quantified against a set
of recombinant antigens including P. falciparum AMA-1 (AMA-1-
FVO/3D7), MSP-1 42 kDa and MSP-2 (MSP-2_CH150/9).
AMA-1 and MSP-1 were histidine-tagged fusion proteins kindly
given by Dr Francis Ndungu (KEMRI, Kilifi) [61], while MSP-2
was a glutathione S-transferase (GST) fusion protein kindly
provided by Dr Faith Osier (KEMRI, Kilifi) [39].
Determination of P. falciparum-specific IgG by ELISA
Whole blood samples were first centrifuged at 1500 g for 10
minutes and plasmas were collected and kept at 280uC for each
individual. Plasma levels of immunoglobulin G (IgG) specific to
PfSE as well as AMA-1, MSP-1 and MSP-2 recombinant antigens
were determined by enzyme-linked immunosorbent assays
(ELISA), as previously described [61]. We confirmed that none
of the plasmas was reacting to uninfected erythrocyte lysate or
GST tag alone using the same procedure. The background
reactivity against these negative controls was subtracted from the
OD values for the corresponding antigen of interest. For AMA-1
and MSP-1 antigens, the mean OD value of sample diluent buffer
alone was subtracted. Plasmas were tested in duplicate (diluted
from 1/250 up to 1/32000 by 8 serialK dilutions) in the presence
of two negative control plasma samples and a sample of pooled
non-immune sera obtained from European donors who have
never been exposed to malaria as well as two positive control
samples and a sample of pooled African immune sera, known to
have high antimalarial Ab concentration. An OD value above the
mean OD value obtained for each antigen with the negative
plasma samples +/23 standard deviations defined a positive Ab
response. Median OD values were used as thresholds (cut-offs) to
characterise IgG Ab reactivity as ‘‘high’’ versus ‘‘low’’ levels for
each antigen. A system of score, from 0 to 4, of how many Ag were
recognised above the cut-offs was then applied to each individual,
where 0 indicates low/undetectable Ab to all 4 tested Ag and 1, 2,
3, 4 denote high levels of Ab to 1, 2, 3 or all 4 Ag, respectively. Of
note, antimalarial Ab levels of the different specificities were
significantly correlated with one another and, for most of them,
there was also a significant correlation with age (data not shown).
Calculation of Malaria Exposure Indexes for Malaria-
exposed Individuals
Malaria exposure indexes were calculated, as described in [42],
as an estimate of individual’s exposure to the infection. They
represent the distance-weighted local prevalence of malaria
infection, i.e. the proportion of individuals with asymptomatic or
symptomatic parasitaemia, within 1 km radius of each indexed
adult between 2009 and 2010, just before the bleed. Clinical and
cross sectional data, from active malaria surveillance in the field,
from 850 individuals were used to estimate the exposure index of
each individual.
PBMC Stimulation
PBMC were distributed in 96-well round-bottom plates at
0.56106/well. Cells were cultured in RPMI medium (RPMI
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1640; Gibco) supplemented with L-glutamine (2 mM; Gibco),
penicillin/streptomycin (10%; Gibco), fœtal calf serum (10%;
Sigma), sodium pyruvate (0.5 mM; Gibco) and Hepes buffer
(6 mM; Gibco). PBMC were stimulated in the presence of
phorbol 12,13-dibutyrate (PdBU, 50 mM; Sigma) and ionomy-
cin (500 ng/ml; Sigma) for 6h at 37uC in 5% CO2. Of note,
PdBU can be substituted by phorbol 12-myristate 13-acetate
(PMA) for PBMC activation. For intracellular cytokine assays,
brefeldin A (10 mg/ml; Sigma) was added after 2 h of activation
during the last 4 h of culture to inhibit protein secretion.
Following 6 h stimulation, cells were harvested, fixed, stained
and analysed as described below.
Antibodies and Reagents
FITC-CD3 (clone OKT3), PE-CD45RA (clone HI100),
PerCPCy5.5-CD28 (clone CD28.2), PECy7-CD4 (clone RPA-
T4), APC-CD197 (CCR7) (clone TG8/CCR7), APCCy7-CD27
(clone O323), Pacific Blue-CD14 (clone HCD14), PE-IL-10
(clone JES3-9D7), PerCPCy5.5-IL-17 (clone BL168), APC-
TNFa (clone mAb11), APCCy7-CD69 (clone FN50), PE-IL-21
(clone 3A3-N2), PE-IL-9 (clone MH9A4), APC-IL-4 (clone 8D4-
8) and PECy7-IL-10 (clone JES3-9D7) monoclonal Ab (mAb) as
well as APC mouse IgG2a, APCCy7 mIgG1, FITC RatIgG2a,
PE mIgG1, PE mIgG2b, PE RatIgG1, PerCPCy5.5 mIgG1,
PECy7 mIgG1 and PECy7 RatIgG1 isotype control Ab were
from Biolegend, Cambridge BioScience. PE/Texas Red-CD4
mAb (clone RFT-4g) was from Southern Biotech, Cambridge
BioScience. PECy7-IFNc mAb (clone 4S.B3) and APC mouse
IgG1 isotype control Ab were purchased from BD Biosciences.
FITC-IL-2 (clone MQ1-17H12) mAb was from eBioscience,
Insight Biotechnology, London, UK. APC-IL-22 mAb (clone
142928) was from R&D System. The reagent panels used in this
study were developed following procedures detailed in [62] and
are presented in Table S1. We titrated each antibody and the
final dilution was selected for an optimal specific staining
associated with a low background using the corresponding
isotype control antibody.
Flow Cytometry Analysis
PBMC were isolated from heparinized blood by Ficoll/
PaqueTM Plus (GE Healthcare) centrifugation and distributed in
96-well round-bottom plates at 0.56106/well. Cells were stained
for 30min at 4uC with appropriate combinations of fluoro-
chrome conjugated mAb in the presence of 5% normal mouse
serum (NMS) and fixed in 2% paraformaldehyde (Sigma) in
PBS. For intracellular staining, fixed cells were permeabilized
and stained in saponin (0.5% in PBS; Sigma) with the different
panels of Ab specific for the cytokines of interest as described in
Table S1, in the presence of 10% NMS. For the determination
of CD4 T cell differentiation profile, phenotypes were assessed
directly ex vivo on fresh unstimulated cells and we excluded
markers, such as CD62L, whose expression can be lost with
cryopreservation [63] in order to be able to apply our assays to
cryopreserved samples. Surface staining was thus performed on
freshly isolated PBMC and at least 200,000 lymphocytes were
acquired using forward scatter (FSC)/side scatter (SSC) gate. T
cell maturation phenotypes were defined by the differential
expression of the cell surface markers CCR7, CD45RA, CD28
and CD27 [4,16]. The markers for the discrimination of the
distinct phenotypes were set using isotype control mAb to define
the threshold of positivity for each marker. Figure S1 shows the
gating strategy for this analysis. For CD4 T cell cytokine
response analysis, PBMC were stimulated non-specifically with
PdBU and ionomycin as described above and the production of
IFNc, IL-2, IL-10, IL-17, TNFa, IL-21, IL-22, IL-4 and IL-9
by CD4 T cells was evaluated using three different panels of Ab
(panels 1–3, Table S1), measuring independently but simulta-
neously up to 5 functions. Panels 1 and 2 defined ‘‘Th1/Th17’’
types of cytokine expression profiles while panel 3 analysed
‘‘Th2/Th9’’ types of cytokine secretion profiles. Surface staining
was performed on activated cells and then followed by
intracellular staining. At least, 35,000 events in the CD4+
lymphocyte gate were analysed for the expression of cytokine.
The gating scheme for this analysis is illustrated in Figure S2.
During the subsequent FC analyses, CD4+ monocytes were
excluded from the CD4 T cell gate by costaining cells with the
monocyte marker CD14. Non-specific background was deter-
mined using isotype matched control mAb and was subtracted
from all the cytokine measurements. Specific cytokine staining
was then confirmed by concomitant cell-surface staining with
CD69 as a marker of activated lymphocytes. Only cells clearly
positive for CD69 were considered as cytokine producing cells.
Within CD69 positive CD4 T cells, the subset of cells
expressing each cytokine was determined. Cells were analysed
using a 9-colour CyAn ADP flow cytometer (Beckman Coulter)
and the data analysis was performed using FlowJo software
version 8.8.7 (TreeStar). For the phenotypic analysis of CD4 T
cell differentiation subsets or to define the quality of CD4 T cell
cytokine response, the subset of cells that express each
functional marker within the CD4 T cell population was
entered into a ‘Boolean gating’ analysis [13] that separately
identifies all the subpopulations expressing each possible
combination of markers or functions. The frequency of each
specific CD4 T cell subpopulation was expressed as a
percentage of CD4 T cells (%). Similarly, the magnitude of
the total cytokine response as well as the frequency of CD4 T
cells producing each particular cytokine was represented as a
percentage of CD4 T cells (%). To analyse the pattern of the
responses i.e. the relative frequency of the different cytokines
within the overall cytokine producing CD4 T cell population or
when CD4 T cell subsets were grouped according to the
number of cytokines they simultaneously expressed, the data
were normalized as follow. The total number of CD4 T cells
positive for at least one cytokine was considered as 100%. The
frequency of each CD4 T cell subpopulation was then expressed
as a fraction of the overall cytokine response by CD4 T cells
(%) by dividing each value by the sum of all the responses with
at least one positive cytokine and multiplying by 100. For the
functional profiling of CD4 T cell cytokine response, only
responses with more than 10 positive events for cytokine
production and a magnitude more than 3 times that of the
background staining with isotype controls were considered.
Statistical Analysis
Statistical analysis was performed in GraphPad Prism software
version 5.0d. Across group comparisons were performed using
Kruskal-Wallis test. When the medians were found to vary
significantly between groups (P,0.05), nonparametric Mann-
Whitney U test was used to analyse differences in the T cell
responses between rural and urban individuals, by pair-wise
comparisons of unpaired samples. Bivariate correlations between
CD4 T cell responses and P. falciparum-specific Ab levels or malaria
exposure indexes were performed using Spearman rank nonpara-
metric correlation test. All tests were 2-tailed, with P,0.05
considered statistically significant. *indicates P,0.05, **P#0.01
and ***P#0.001, respectively. No adjustment was made for
multiple comparisons because this study was by nature explorato-
ry.
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Supporting Information
Figure S1 Gating strategy for polychromatic flow
cytometry analysis of CD4 T cell differentiation profile.
Initial gating was performed on lymphocytes and singlets only
were included in the analysis. CD4 T cells were then gated based
on the concomitant expression of CD3 and CD4. Within the CD4
T cell population, the subset of cells expressing each marker was
determined. Isotype matched control mAb were used to set up the
threshold of positivity for each marker as shown below each plot.
The plots shown are representative of all the analysed samples.
(TIF)
Figure S2 Gating strategy for CD4 T cell cytokine
production analysis. The analysis was initially gated on
lymphocytes and only singlets were included. CD4 T cells were
then gated based on both the expression of CD4 and the lack of
expression of the monocyte marker CD14. Within the CD4 T cell
population, only cells clearly positive for CD69 were considered as
cytokine producing cells and included in the analysis. Within the
CD4 T cells CD69 positive, the subset expressing each cytokine of
interest (IFNc, IL-2, IL-10, IL-17, TNFa, IL-21, IL-22, IL-4 and
IL-9, respectively) was defined. Non-specific background was
determined using isotype matched control Ab as shown below
each plot for cytokine staining and was subtracted from all the
data. The plots shown are representative of all the analysed
samples.
(TIF)
Figure S3 Functional characterization of CD4 T cell
cytokine response by Boolean gating analysis. The
composition of the CD4 T cell cytokine responses from each
group of donors was analysed using three different panels of Ab
(panel 1–3 Table S1). For simplicity, only the individual
combinations of cytokines observed in all three groups are shown.
The contribution of the indicated functional response (x-axis)
toward the total CD4 T cell cytokine response is expressed as a
percentage (medians and 95% confidence intervals are represent-
ed) and compared between each group of donors (rural African
donors (RA, n = 25); urban African (UA, n = 8) and European
donors (UE, n = 8)). The cytokine combinations are indicated in
the panel below each plot. Each dot denotes positivity for each
cytokine indicated on the left. A shows the data obtained with
panel 1, while B and C represent the results obtained with panel 2
and 3, respectively. Differences in the relative frequency of each
CD4 T cell subset across groups were tested using Kruskal-Wallis
test (data not shown) and where significance was obtained, Mann-
Whitney U test was used for pair-wise analysis between groups.
Significant differences are indicated by an asterisk. *indicates
P,0.05, **P#0.01 and ***P#0.001, respectively.
(TIF)
Figure S4 Specific IgG Ab responses to malarial anti-
gens. Levels of antimalarial serum IgG were determined by
antigen specific ELISA. Ab levels are expressed by the OD values
obtained with the sera dilution 1/500 and shown for each tested P.
falciparum antigen i.e. total schizont extracts (PfSE), AMA-1, MSP-
1 and MSP-2, respectively. Shown is the comparison of Ab levels
between rural African donors (RA, black circles), endemically
exposed to malaria, and urban unexposed African (UA, black
squares) and European donors (UE, black triangles). Bars indicate
mean +/295% confidence intervals. Mann-Whitney U test was
used for pair-wise analysis of the differences in Ab levels between
the rural African individuals and each urban group. Statistically
significant P-values (,0.05) are indicated by an aster-
isk(****P#0.0001).
(TIF)
Figure S5 Endemic exposure to malaria influences IFNc
and IL-10 expression profile by CD4 T cells. (A) CD4 T
cell responses from each group of donors were analysed using
panel 1 (Table S1) as shown in more detail in Figure S3A. For
simplicity, here is only represented the pattern of IFNc and IL-10
production by CD4 T cells. The relative proportion of CD4 T cells
producing each combination of cytokines (shown in the panel on
the right) is represented as a percentage of the total CD4 T cell
IFNc and IL-10 response (mean with SEM are shown for each
group) and was compared between the 3 groups of donors (rural
African (RA), urban African (UA) and urban European donors
(UE)). Each dot denotes the expression of IFNc or IL-10 as
indicated on the left. CD4 T cell subsets were then ordered
according to the number of cytokines they expressed, as specified
by the horizontal bars of different colours showing these
combinations of 2 or 1 cytokine. B shows the trend towards a
negative and a positive correlation between malaria exposure and
the relative frequencies of IFNc single producers (SP) and IFNc/
IL-10 double producers (DP), respectively. The relative frequency
of IFNc producing CD4 T cells expressing IFNc alone or in
combination with IL-10 is plotted against malaria exposure
indexes. Spearman’s correlation coefficients r and P-values are
indicated for each plot.
(TIF)
Table S1 Panels for phenotypic and functional charac-
terization of CD4 T cell population by polychromatic
flow cytometry. FITC, fluorescein; PE, R-phycoerythrin;
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